Search

everythinglearnresearchcommunity

for

Search:↓

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Omalizumab may cause hair loss.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.